{
    "2020-09-09": [
        [
            {
                "time": "2020-09-08",
                "original_text": "AstraZeneca Just Sneezed. Will Other Vaccine Makers Catch Cold?",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "vaccine",
                        "makers",
                        "catch cold"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Pfizer (PFE) Gains But Lags Market: What You Should Know",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "gains",
                        "lags market"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Coronavirus Vaccine Developers Jump As Rival AstraZeneca Pauses Trials",
                "features": {
                    "keywords": [
                        "vaccine",
                        "developers",
                        "jump",
                        "AstraZeneca",
                        "pauses trials"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Trump Admits to Downplaying Danger of Virus, According to Reports",
                "features": {
                    "keywords": [
                        "Trump",
                        "downplaying",
                        "virus",
                        "danger"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "politics",
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Pfizer and BioNTech to Potentially Sell 300 Million Doses of Its Coronavirus Vaccine to EU",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "vaccine",
                        "EU",
                        "sell"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Traders Are Getting Smarter About the Vaccine Race",
                "features": {
                    "keywords": [
                        "traders",
                        "vaccine",
                        "race",
                        "smarter"
                    ],
                    "sentiment_score": 0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "finance"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Fauci Says Pause on Vaccine Trial Not Uncommon",
                "features": {
                    "keywords": [
                        "Fauci",
                        "vaccine",
                        "trial",
                        "pause",
                        "uncommon"
                    ],
                    "sentiment_score": 0.1,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "science"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Pfizer, BioNTech Ink Covid Vaccine Deal With EU, Post Positive Trial Data",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "vaccine",
                        "EU",
                        "deal",
                        "positive data"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "Pfizer, BioNTech Rally On A Trio Of Catalysts",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "BioNTech",
                        "rally",
                        "catalysts"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2020-09-09",
                "original_text": "AstraZeneca’s Vaccine-Trial Pause Won’t Slow Its Rivals",
                "features": {
                    "keywords": [
                        "AstraZeneca",
                        "vaccine",
                        "trial pause",
                        "rivals"
                    ],
                    "sentiment_score": 0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}